Takawira Faustinos Tatenda, Mandishora Racheal Shamiso Dube, Dhlamini Zephaniah, Munemo Ellen, Stray-Pedersen Babill
Department of Applied Biology and Biochemistry, National University of Science and Technology (NUST), Bulawayo, Zimbabwe.
Department of Microbiology, College of Health Sciences, University of Zimbabwe, Mazowe Street, Parirenyatwa Complex, Avondale, Harare, Zimbabwe.
Pan Afr Med J. 2017 Jun 28;27:145. doi: 10.11604/pamj.2017.27.145.10883. eCollection 2017.
Tuberculosis remains the leading causes of death worldwide with frequencies of mutations in rifampicin and isoniazid resistant Mycobacterium tuberculosis isolates varying according to geographical location. There is limited information in Zimbabwe on specific antibiotic resistance gene mutation patterns in MTB and hence, increased rate of discordant results and mortality due to inappropriate antibiotic prescriptions. The rpoB and katG genes molecular markers are used for detecting rifampicin and isoniazid resistance respectively. Some mutations within these gene sequences are associated with drug resistance as they directly alter gene function. The objectives of this research was to determine the drug resistance profiles in M. tuberculosis isolates that are phenotypically resistant but not detected by the GeneXpert and MTBDRplus kit and also to detect mutations in the rpoB and katG genes which are not detected by the Hain Genotype MTBDRplus kit and GeneXpert diagnosis.
PCR was used for the amplification of the rpoB and katG genes from MTB isolates collected from human clinical samples between 2008 and 2015. The genes were sequenced and compared to the wild type MTB H37Rv rpoB (accession number L27989) and kat G genes (KP46920), respectively. Sequence analysis results were compared to genotyping results obtained from molecular assays and culture results of all isolates.
The most frequent mutation responsible for rifampicin resistance was (25/92) S531L that was detected by using all molecular assays. Some inconsistencies were observed between phenotypic and genotypic assay results for both katG and rpoB genes in 30 strains. For these, eight codons; G507S, T508A, L511V, del513-526, P520P, L524L, R528H, R529Q and S531F were novel mutations. In addition, the I572P/F, E562Q, P564S, and Q490Y mutations were identified as novel mutations outside the rifampicin resistance determining region. In katG gene, amino acid changes to threonine, asparagine and isoleucine exhibited high degrees of polymorphism such as V473N, D311N, and L427I. The R463L (20/92) amino acid substitution was most common but was not associated with isoniazid resistance.
These finding indicate that molecular assay kit diagnosis that is based on the rpoB and katG genes should be improved to cater for the genetic variations associated with the geographic specificity of the target genes and be able to detect most prevalent mutations in different areas.
结核病仍然是全球主要死因,耐利福平及异烟肼结核分枝杆菌分离株的突变频率因地理位置而异。在津巴布韦,关于结核分枝杆菌中特定抗生素耐药基因突变模式的信息有限,因此,因抗生素处方不当导致的结果不一致和死亡率上升。rpoB和katG基因分子标记分别用于检测利福平和异烟肼耐药性。这些基因序列中的一些突变与耐药性相关,因为它们直接改变基因功能。本研究的目的是确定表型耐药但未被GeneXpert和MTBDRplus试剂盒检测到的结核分枝杆菌分离株的耐药谱,同时检测未被海因基因型MTBDRplus试剂盒和GeneXpert诊断检测到的rpoB和katG基因中的突变。
采用聚合酶链反应(PCR)从2008年至2015年从人类临床样本中收集的结核分枝杆菌分离株中扩增rpoB和katG基因。对这些基因进行测序,并分别与野生型结核分枝杆菌H37Rv的rpoB(登录号L27989)和katG基因(KP46920)进行比较。将序列分析结果与所有分离株的分子检测基因分型结果和培养结果进行比较。
导致利福平耐药的最常见突变是(25/92)S531L,所有分子检测均检测到该突变。在30株菌株中,katG和rpoB基因的表型和基因型检测结果之间存在一些不一致。对于这些菌株,八个密码子;G507S、T508A、L511V、del513 - 526、P520P、L524L、R528H、R529Q和S531F是新的突变。此外,I572P/F、E562Q、P564S和Q490Y突变被鉴定为利福平耐药决定区以外的新突变。在katG基因中,氨基酸变为苏氨酸、天冬酰胺和异亮氨酸表现出高度多态性,如V473N、D311N和L427I。R463L(20/92)氨基酸替代最为常见,但与异烟肼耐药性无关。
这些发现表明,基于rpoB和katG基因的分子检测试剂盒诊断应加以改进,以适应与目标基因地理特异性相关的基因变异,并能够检测不同地区最普遍的突变。